Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study (English)
- New search for: Marechal, R.
- New search for: Vos, B.
- New search for: Polus, M.
- New search for: Delaunoit, T.
- New search for: Peeters, M.
- New search for: Demetter, P.
- New search for: Hendlisz, A.
- New search for: Demols, A.
- New search for: Franchimont, D.
- New search for: Verset, G.
- New search for: Marechal, R.
- New search for: Vos, B.
- New search for: Polus, M.
- New search for: Delaunoit, T.
- New search for: Peeters, M.
- New search for: Demetter, P.
- New search for: Hendlisz, A.
- New search for: Demols, A.
- New search for: Franchimont, D.
- New search for: Verset, G.
In:
ANNALS OF ONCOLOGY
;
23
, 6
;
1525-1530
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
-
Contributors:Marechal, R. ( author ) / Vos, B. ( author ) / Polus, M. ( author ) / Delaunoit, T. ( author ) / Peeters, M. ( author ) / Demetter, P. ( author ) / Hendlisz, A. ( author ) / Demols, A. ( author ) / Franchimont, D. ( author ) / Verset, G. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 6 ; 1525-1530
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 6
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1373
-
Predicting and accounting for VTE in phase I cancer studiesKhorana, A. A. et al. | 2012
- 1375
-
Endocrine-responsive breast cancer special types: who cares?Bonnefoi, H. / MacGrogan, G. et al. | 2012
- 1378
-
The sequential use of endocrine treatment for advanced breast cancer: where are we?Barrios, C. / Forbes, J. F. / Jonat, W. / Conte, P. / Gradishar, W. / Buzdar, A. / Gelmon, K. / Gnant, M. / Bonneterre, J. / Toi, M. et al. | 2012
- 1387
-
Vaccination therapy for non-small-cell lung cancer: review of agents in phase III developmentDecoster, L. / Wauters, I. / Vansteenkiste, J. F. et al. | 2012
- 1394
-
Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studiesAune, D. / Chan, D. S. / Greenwood, D. C. / Vieira, A. R. / Rosenblatt, D. A. / Vieira, R. / Norat, T. et al. | 2012
- 1403
-
Aspirin and cancer risk: a quantitative review to 2011Bosetti, C. / Rosato, V. / Gallus, S. / Cuzick, J. / La Vecchia, C. et al. | 2012
- 1416
-
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the `SENDO experience'Mandala, M. / Clerici, M. / Corradino, I. / Vitalini, C. / Colombini, S. / Torri, V. / De Pascale, A. / Marsoni, S. et al. | 2012
- 1422
-
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyPsyrri, A. / Kalogeras, K. T. / Kronenwett, R. / Wirtz, R. M. / Batistatou, A. / Bournakis, E. / Timotheadou, E. / Gogas, H. / Aravantinos, G. / Christodoulou, C. et al. | 2012
- 1428
-
Outcome of special types of luminal breast cancerColleoni, M. / Rotmensz, N. / Maisonneuve, P. / Mastropasqua, M. G. / Luini, A. / Veronesi, P. / Intra, M. / Montagna, E. / Cancello, G. / Cardillo, A. et al. | 2012
- 1436
-
Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancerGori, S. / Montemurro, F. / Spazzapan, S. / Metro, G. / Foglietta, J. / Bisagni, G. / Ferzi, A. / Silva, R. R. / Gamucci, T. / Clavarezza, M. et al. | 2012
- 1441
-
A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancerAogi, K. / Iwata, H. / Masuda, N. / Mukai, H. / Yoshida, M. / Rai, Y. / Taguchi, K. / Sasaki, Y. / Takashima, S. et al. | 2012
- 1449
-
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upHaest, K. / Kumar, A. / Van Calster, B. / Leunen, K. / Smeets, A. / Amant, F. / Berteloot, P. / Wildiers, H. / Paridaens, R. / Van Limbergen, E. et al. | 2012
- 1455
-
The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancerLaBonte, M. J. / Wilson, P. M. / Yang, D. / Zhang, W. / Ladner, R. D. / Ning, Y. / Gerger, A. / Bohanes, P. O. / Benhaim, L. / El-khoueiry, R. et al. | 2012
- 1465
-
Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinicSyed, B. M. / Johnston, S. J. / Wong, D. W. / Green, A. R. / Winterbottom, L. / Kennedy, H. / Simpson, N. / Morgan, D. A. / Ellis, I. O. / Cheung, K. L. et al. | 2012
- 1471
-
Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effectsPemmaraju, N. / Munsell, M. F. / Hortobagyi, G. N. / Giordano, S. H. et al. | 2012
- 1474
-
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)Zaman, K. / Thurlimann, B. / Huober, J. / Schonenberger, A. / Pagani, O. / Luthi, J. / Simcock, M. / Giobbie-Hurder, A. / Berthod, G. / Genton, C. et al. | 2012
- 1481
-
Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter studyFauvet, R. / Brzakowski, M. / Morice, P. / Resch, B. / Marret, H. / Graesslin, O. / Darai, E. et al. | 2012
- 1488
-
Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in ItalyRossi, M. / Lugo, A. / Lagiou, P. / Zucchetto, A. / Polesel, J. / Serraino, D. / Negri, E. / Trichopoulos, D. / La Vecchia, C. et al. | 2012
- 1494
-
Importance of gender in diffuse malignant peritoneal mesotheliomaCao, C. / Yan, T. D. / Deraco, M. / Elias, D. / Glehen, O. / Levine, E. A. / Moran, B. J. / Morris, D. L. / Chua, T. C. / Piso, P. et al. | 2012
- 1499
-
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working PartyDArena, G. / Valentini, C. G. / Pietrantuono, G. / Guariglia, R. / Martorelli, M. C. / Mansueto, G. / Villani, O. / Onofrillo, D. / Falcone, A. / Specchia, G. et al. | 2012
- 1503
-
Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancerCen, P. / Liu, C. / Du, X. L. et al. | 2012
- 1512
-
Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trialFerri, L. E. / Ades, S. / Alcindor, T. / Chasen, M. / Marcus, V. / Hickeson, M. / Artho, G. / Thirlwell, M. P. et al. | 2012
- 1518
-
PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysisMao, C. / Yang, Z. Y. / Hu, X. F. / Chen, Q. / Tang, J. L. et al. | 2012
- 1525
-
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II studyMarechal, R. / Vos, B. / Polus, M. / Delaunoit, T. / Peeters, M. / Demetter, P. / Hendlisz, A. / Demols, A. / Franchimont, D. / Verset, G. et al. | 2012
- 1531
-
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin CPrice, T. J. / Zannino, D. / Wilson, K. / Simes, R. J. / Cassidy, J. / Van Hazel, G. A. / Robinson, B. A. / Broad, A. / Ganju, V. / Ackland, S. P. et al. | 2012
- 1537
-
Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancerHayashi, H. / Okamoto, I. / Morita, S. / Taguri, M. / Nakagawa, K. et al. | 2012
- 1542
-
Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapyStorey, D. J. / McLaren, D. B. / Atkinson, M. A. / Butcher, I. / Frew, L. C. / Smyth, J. F. / Sharpe, M. et al. | 2012
- 1549
-
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyHeng, D. Y. / MacKenzie, M. J. / Vaishampayan, U. N. / Bjarnason, G. A. / Knox, J. J. / Tan, M. H. / Wood, L. / Wang, Y. / Kollmannsberger, C. / North, S. et al. | 2012
- 1555
-
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMSHouot, R. / Le Gouill, S. / Ojeda Uribe, M. / Mounier, C. / Courby, S. / Dartigeas, C. / Bouabdallah, K. / Alexis Vigier, M. / Moles, M. P. / Tournilhac, O. et al. | 2012
- 1562
-
A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACCChau, N. G. / Hotte, S. J. / Chen, E. X. / Chin, S. F. / Turner, S. / Wang, L. / Siu, L. L. et al. | 2012
- 1571
-
Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient servicesKlafke, N. / Eliott, J. A. / Wittert, G. A. / Olver, I. N. et al. | 2012
- 1579
-
Internet use by cancer patients: should oncologists `prescribe' accurate web sites in combination with chemotherapy? A survey in a Spanish cohortLopez-Gomez, M. / Ortega, C. / Suarez, I. / Serralta, G. / Madero, R. / Gomez-Raposo, C. / Sereno, M. / Casado, E. / Espinosa, E. / Lobo, F. et al. | 2012
- 1586
-
Alcohol drinking and bladder cancer risk: a meta-analysisPelucchi, C. / Galeone, C. / Tramacere, I. / Bagnardi, V. / Negri, E. / Islami, F. / Scotti, L. / Bellocco, R. / Corrao, G. / Boffetta, P. et al. | 2012
- 1593
-
Large body size and sedentary lifestyle during childhood and early adulthood and esophageal squamous cell carcinoma in a high-risk populationEtemadi, A. / Golozar, A. / Kamangar, F. / Freedman, N. D. / Shakeri, R. / Matthews, C. / Islami, F. / Boffetta, P. / Brennan, P. / Abnet, C. C. et al. | 2012
- 1601
-
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survivalItaliano, A. / Toulmonde, M. / Cioffi, A. / Penel, N. / Isambert, N. / Bompas, E. / Duffaud, F. / Patrikidou, A. / Lortal, B. / Le Cesne, A. et al. | 2012
- 1607
-
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsWhelan, J. S. / Jinks, R. C. / McTiernan, A. / Sydes, M. R. / Hook, J. M. / Trani, L. / Uscinska, B. / Bramwell, V. / Lewis, I. J. / Nooij, M. A. et al. | 2012
- 1617
-
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistancevan Oosterwijk, J. G. / Herpers, B. / Meijer, D. / Briaire-de Bruijn, I. H. / Cleton-Jansen, A. M. / Gelderblom, H. / van de Water, B. / Bovee, J. V. et al. | 2012
- 1626
-
Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphomavan Waas, M. / Neggers, S. J. / te Winkel, M. L. / Beishuizen, A. / Pieters, R. / van den Heuvel-Eibrink, M. M. et al. | 2012
- 1633
-
Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trialsYou, B. / Pond, G. / Siu, L. L. / Nagai, J. / Cheiken, R. / Chen, E. et al. | 2012
- 1640
-
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndromeVadhan-Raj, S. / Fayad, L. E. / Fanale, M. A. / Pro, B. / Rodriguez, A. / Hagemeister, F. B. / Bueso-Ramos, C. E. / Zhou, X. / McLaughlin, P. W. / Fowler, N. et al. | 2012
- 1646
-
Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end pointsKay, A. / Higgins, J. / Day, A. G. / Meyer, R. M. / Booth, C. M. et al. | 2012